Senior insider sale
PRESIDENT AND CEO at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$99.0K
16.94K shares
What this filing means
AUERBACH ALAN H plans to sell 16.94K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $99.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/6/2026ACC: 0001959173-26-000165
DirectorOfficer10% Owner· PRESIDENT AND CEO
Since Jul 2018
16.94K
Shares to sell
$99.0K
Approx. market value
16.94K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
1/2/2026
16.94KTotal acquired16.94K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2026 | Restricted Stock Vesting Compensation | 16.94K | — |
| Total | 16.94K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
16.94K
Market value
$99.0K
1/6/2026
Total
Units
16.94K
Value
$99.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/6/2026 | 16.94K | $99.0K | NASDAQ | Planned |
| Total | 16.94K | $99.0K | ||